18 studies found for:    " April 11, 2007":" May 11, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Terminated PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
Conditions: HIV-Dementia;   HIV-Associated Cognitive Motor Complex;   AIDS Encephalopathy;   AIDS Dementia Complex;   AIDS-Related Dementia Complex;   HIV Infections;   Healthy
Intervention: Drug: [11C]PBR28
2 Recruiting Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Metreleptin (Leptin)
3 Completed Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
Conditions: Tuberculosis;   Latent Tuberculosis Infection;   HIV Infections
Interventions: Drug: isoniazid;   Drug: Placebo
4 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
Conditions: HIV Infections;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: Valacyclovir;   Drug: Matching Placebo
5 Completed Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
Condition: HIV Infections
Interventions: Biological: VRC-HIVADV027-00-VP;   Biological: VRC-HIVADV038-00-VP;   Biological: VRC-HIVDNA044-00-VP
6 Completed A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method
Condition: HIV Infections
Intervention: Device: intravaginal ring
7 Completed Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: darunavir/ritonavir;   Drug: etravirine;   Drug: Optimized background regimen
8 Completed A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium
Condition: HIV Infections
Interventions: Drug: dapivirine reservoir intravaginal ring;   Drug: dapivirine matrix intravaginal ring;   Other: placebo intravaginal ring
9 Completed Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
Conditions: HIV Infections;   Insulin Resistance;   Hyperlactatemia
Intervention: Drug: NucleomaxX (contains uridine)
10 Completed LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Conditions: HIV Infections;   Diffuse Large B Cell Lymphoma
Interventions: Drug: R-CHOP;   Drug: Highly active antiretroviral therapy;   Drug: Central nervous system (CNS) prophylaxis;   Drug: Prophylaxis of opportunistic infections and support treatment
11 Completed
Has Results
The Treatment of Insomnia in Patients With HIV Disease
Conditions: HIV Infections;   Insomnia
Interventions: Drug: Doxepin;   Drug: Temazepam;   Drug: Placebo
12 Completed Behavioral, Clinical and Basic Science Studies of Non-Occupational Post-Exposure Prophylaxis ("PEP-2")
Condition: HIV Infections
Intervention: Behavioral: standard versus enhanced risk reduction counseling
13 Completed HIV and Cardiovascular Risk
Conditions: HIV Infections;   Cardiovascular Disease
Intervention:
14 Completed Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week;   Drug: Ribavirin (Copegus®) 1600 mg/day;   Drug: Epoetin β (450 UI/kg/week)
15 Terminated ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Antiretroviral therapy
16 Completed Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Behavioral: Nevirapine from twice-a-day to once-a-day
17 Completed
Has Results
Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
Condition: HIV
Intervention: Drug: TMC125, Darunavir; Ritonavir
18 Completed 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides
Condition: Sexually Transmitted Infections
Interventions: Other: 62% ethanol in emollient gel;   Drug: Placebo;   Other: 15% ethanol in emollient gel

Indicates status has not been verified in more than two years